D. D. Wagner and V. J. Marder, Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain, J. Biol. Chem, pp.258-2065, 1983.

I. Corrales, L. Ramirez, C. Altisent, R. Parra, and F. Vidal, The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients' platelets and leukocytes, J. Thromb. Haemost, vol.9, pp.679-688, 2011.

J. C. Eikenboom, Congenital von Willebrand disease type3: clinical manifestations, pathophysiology and molecular biology, Best Pract. Res. Clin. Haematol, vol.14, pp.365-379, 2001.
DOI : 10.1053/beha.2001.0139

H. , L. Hir, and B. Seraphin, EJCs at the heart of translational control, Cell, vol.133, pp.213-216, 2008.

F. Xie, X. Wang, D. N. Cooper, F. Lan, Y. Fang et al., Compound heterozygosity for two novel mutations (1203insG/Y1456X) in the von Willebrand factor gene causing, Haemophilia, vol.13, pp.645-648, 2007.

G. Castaman, M. Plate, S. H. Giacomelli, F. Rodeghiero, and S. Duga, Alterations of mRNA processing and stability as a pathogenic mechanism in von Willebrand factor quantitative deficiencies, J. Thromb. Haemost, vol.8, pp.2736-2742, 2010.

M. Plate, S. Duga, L. Baronciani, S. L. Marca, V. Rubini et al., Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay, Haematologica, vol.95, pp.172-174, 2010.

J. Cejka, Enzyme immunoassay for factor VIII-related antigen, Clin. Chem, vol.28, pp.1356-1358, 1982.

S. Shahbazi, R. Mahdian, F. A. Ala, J. M. Lavergne, C. V. Denis et al., Molecular characterization of Iranian patients with type 3 von Willebrand disease, Haemophilia, vol.15, pp.1058-1064, 2009.

D. E. Macfarlane, J. Stibbe, E. P. Kirby, M. B. Zucker, R. A. Grant et al., Letter: a method for assaying von Willebrand factor (ristocetin cofactor), Thromb. Diath. Haemorrh, pp.34-306, 1975.

R. Kerr, D. Stirling, M. Rae, A. R. White, and C. A. Ludlam, A novel method for quantitation of human von Willebrand factor messenger RNA, Thromb. Res, vol.106, pp.237-241, 2002.

J. M. Rox, P. Bugert, J. Muller, A. Schorr, P. Hanfland et al., Gene expression analysis in platelets from a single donor: evaluation of a PCR-based amplification technique, Clin. Chem, pp.50-2271, 2004.

K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(?Delta Delta C(T)) method, Methods, vol.25, pp.402-408, 2001.

]. L. Baronciani, G. Cozzi, M. T. Canciani, F. Peyvandi, A. Srivastava et al., Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients, Blood Cells Mol. Dis, pp.30-264, 2003.

O. Isken and L. E. Maquat, Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function, Genes Dev, vol.21, pp.1833-1856, 2007.

P. H. Byers, Killing the messenger: new insights into nonsense-mediated mRNA decay, J. Clin. Invest, vol.109, pp.3-6, 2002.

W. C. Nichols, S. E. Lyons, J. S. Harrison, R. L. Cody, and D. Ginsburg, Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis, Proc. Natl. Acad. Sci. U. S. A, pp.88-3857, 1991.

K. L. Mohlke, W. C. Nichols, A. Rehemtulla, R. J. Kaufman, H. M. Fagerstrom et al., A common frameshift mutation in von Willebrand factor does not alter mRNA stability but interferes with normal propeptide processing, Br. J. Haematol, pp.95-184, 1996.

J. C. Eikenboom, H. K. Ploos-van-amstel, P. H. Reitsma, and E. Briet, Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA, Thromb. Haemost, pp.68-448, 1992.

K. Peerlinck, J. C. Eikenboom, H. K. Van-amstel, W. Sangtawesin, J. Arnout et al., A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele, Br. J. Haematol, vol.80, pp.358-363, 1992.

E. H. Sohn, H. S. Kim, A. Y. Lee, T. Fukuda, H. Sugie et al., A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay, Neuromuscul. Disord, vol.18, pp.886-889, 2008.

L. E. Maquat, Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics, Nat. Rev. Mol. Cell Biol, vol.5, pp.89-99, 2004.